Benzinga | Nov 15, 2021 06:34PM EST

INVO Bioscience Q3 EPS $(0.24) Misses $(0.20) Estimate, Adj. EBITDA Loss $1.6M, Sales $218.87K Miss $330.00K Estimate

INVO Bioscience (NASDAQ:INVO) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.20) by 20 percent. This is a 33.33 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $218.87 thousand which missed the analyst consensus estimate of $330.00 thousand by 33.67 percent. This is a 34.87 percent decrease over sales of $336.07 thousand the same period last year.